IBJNews

Lilly stomach-cancer drug helps survival, study finds

Back to TopCommentsE-mailPrintBookmark and Share

Eli Lilly and Co. shares rose nearly 5 percent Monday morning after it said a study found that its experimental stomach-cancer drug helped patients with advanced disease live longer.

The most common side effect for the medicine, called ramucirumab, was high blood pressure, diarrhea and headache, the Indianapolis-based company said in a prepared statement. The drug was tested in patients with gastric cancer that had spread to other parts of the body.

Leerink Swann upgraded its rating on the stock to buy from hold on the data, saying the drug has an 80-percent chance of approval as a second-line treatment. The medicine is in the final stage of testing for U.S regulatory approval. If approved, it may generate $600 million in annual sales, said Mark Schoenebaum, a New York-based analyst with ISI Group.

“Overall, the Street will view this positively, we think, as it adds credence to the pipeline thesis,” Schoenebaum said, in a note to clients. He said it will also make Lilly less dependent in the future on its experimental Alzheimer’s drug.

Lilly shares rose 4.8 percent, to $52.86 each, late in the morning and were up 32 percent in the 12 months through Sunday. Shares in Dyax Corp, which has a partnership on the treatment, rose 28 cents, or 12 percent, to $2.66.

Leerink analyst Seamus Fernandez said in a report Monday that the stock could hit $59 to $60 a share based on his positive outlook for the drug.

Lilly didn’t disclose the increase in the survival benefit. Full results from the research will be presented at a future medical meeting, the drugmaker said.

Ramucirumab is among the products obtained by Lilly from its $6.5 billion acquisition of ImClone Systems Inc. in 2008. Lilly has five other late-stage studies of ramucirumab ongoing in four tumor types, including breast and lung cancer. If approved for all indications in testing, the drug could have $1.6 billion in sales by 2020, Fernandez said.

More than 21,000 people will be diagnosed with stomach cancer in the U.S. in 2012 and 10,540 people will die of the disease, according to the National Cancer Institute.

ADVERTISEMENT

  • Stomach Support | Digestion Help | Stomach Help | IBS | SIBO
    thank you for this post. Stomach Help Digestion Help stomach support SIBO Digestion Help stomach help Informational blog for people suffering from stomach disorders or general stomach problems. digestion help, stomach help, IBS, SIBO, stomach support. A healthy stomach is vital for a smooth functioning body. Many illnesses and diseases can be traced to the improper working of this organ. Therefore, one must take particular care of the stomach and take the smallest of stomach help seriously. The best kind of stomach help is to take in healthy foods that have not been exposed to a lot of processing or chemical treatment. Foods that are high in preservatives or artificial coloring can create general stomach issues. Organically grown foods are not only tastier and healthier, but are easier to digest because they contain natural fibre that aids in digestion help.

Post a comment to this story

COMMENTS POLICY
We reserve the right to remove any post that we feel is obscene, profane, vulgar, racist, sexually explicit, abusive, or hateful.
 
You are legally responsible for what you post and your anonymity is not guaranteed.
 
Posts that insult, defame, threaten, harass or abuse other readers or people mentioned in IBJ editorial content are also subject to removal. Please respect the privacy of individuals and refrain from posting personal information.
 
No solicitations, spamming or advertisements are allowed. Readers may post links to other informational websites that are relevant to the topic at hand, but please do not link to objectionable material.
 
We may remove messages that are unrelated to the topic, encourage illegal activity, use all capital letters or are unreadable.
 

Messages that are flagged by readers as objectionable will be reviewed and may or may not be removed. Please do not flag a post simply because you disagree with it.

Sponsored by
ADVERTISEMENT

facebook - twitter on Facebook & Twitter

Follow on TwitterFollow IBJ on Facebook:
Follow on TwitterFollow IBJ's Tweets on these topics:
 
Subscribe to IBJ
  1. How can any company that has the cash and other assets be allowed to simply foreclose and not pay the debt? Simon, pay the debt and sell the property yourself. Don't just stiff the bank with the loan and require them to find a buyer.

  2. If you only knew....

  3. The proposal is structured in such a way that a private company (who has competitors in the marketplace) has struck a deal to get "financing" through utility ratepayers via IPL. Competitors to BlueIndy are at disadvantage now. The story isn't "how green can we be" but how creative "financing" through captive ratepayers benefits a company whose proposal should sink or float in the competitive marketplace without customer funding. If it was a great idea there would be financing available. IBJ needs to be doing a story on the utility ratemaking piece of this (which is pretty complicated) but instead it suggests that folks are whining about paying for being green.

  4. The facts contained in your post make your position so much more credible than those based on sheer emotion. Thanks for enlightening us.

  5. Please consider a couple of economic realities: First, retail is more consolidated now than it was when malls like this were built. There used to be many department stores. Now, in essence, there is one--Macy's. Right off, you've eliminated the need for multiple anchor stores in malls. And in-line retailers have consolidated or folded or have stopped building new stores because so much of their business is now online. The Limited, for example, Next, malls are closing all over the country, even some of the former gems are now derelict.Times change. And finally, as the income level of any particular area declines, so do the retail offerings. Sad, but true.

ADVERTISEMENT